PharmaVoice Logo

Healthcare Leaders Hub

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

Pharma Tech

Oct 25, 2026, 7:24 AM

ESMO26: Oral cell cycle inhibitors place Cyclin E1 as new target in PROC

Data for the two PROC candidates that act on Cyclin E1 were presented at ESMO26.

ET Pharma

Oct 24, 2026, 3:17 PM

Kilitch Drugs divests Ethiopian arm for $14 million to fund mfg expansion

The company said the net proceeds will be channeled towards supporting the phased expansion of its new manufacturing facility at Pen, Maharashtra.

ET Pharma

Oct 24, 2026, 2:20 PM

GLP-1 boom in China, India, Brazil could create $22 billion market by 2035, J.P. Morgan says

China and India are home to some of the world's largest diabetes patient populations, accounting for more than 25% and 15% of global diagnosed cases, respectively, while about 12% of Brazilian adults have diabetes, according to J.P. Morgan.

Express Pharma

Oct 24, 2026, 12:55 PM

Government sets up panel to review pharma marketing rules

Three-member committee to assess whether existing safeguards against unethical marketing are effective and recommend changes to improve monitoring and enforcement. The post Government sets up panel to review pharma marketing rules appeared first on Express Pharma.

ET Pharma

Oct 23, 2026, 11:18 PM

Dr Reddy's rolls out new generic Ozempic brands to ease Obeda supply hit

Obeda Pro and Obeda Plus are manufactured by a different firm than the Obeda injectable, supplies of which were halted after Dr Reddy's found an impurity in the active ingredient.

Pharma Tech

Oct 23, 2026, 3:17 PM

US targets Chinese biotech investment, but licensing deals remain exempt

Numerous types of equity deals involving Chinese biotech, including the popular NewCo model, will be impacted by the proposed rule.

News

Latest industry coverage

Google News

Oct 25, 2026, 7:29 AM

ESMO26: Oral cell cycle inhibitors place Cyclin E1 as new target in PROC - Pharmaceutical Technology

ESMO26: Oral cell cycle inhibitors place Cyclin E1 as new target in PROCĀ Ā Pharmaceutical Technology

Google News

Oct 25, 2026, 7:22 AM

Lim Jong-yun (Chairman), Hanmi Pharmaceutical Special Audit Demand…Management Rights Dispute Intensifies - ėØøė‹ˆķˆ¬ė°ģ“

Lim Jong-yun (Chairman), Hanmi Pharmaceutical Special Audit Demand…Management Rights Dispute IntensifiesĀ Ā ėØøė‹ˆķˆ¬ė°ģ“

Google News

Oct 25, 2026, 2:25 AM

China's Pharma Licensing Deals Top $138.8 Billion, With $150.9 Billion in Sight This Year - BigGo Finance

China's Pharma Licensing Deals Top $138.8 Billion, With $150.9 Billion in Sight This YearĀ Ā BigGo Finance

Google News

Oct 25, 2026, 1:28 AM

China Emerges as Global Drug Development Hub... Tech Exports Hit KRW 184 Trillion This Year - ģ•„ģ‹œģ•„ź²½ģ œ

China Emerges as Global Drug Development Hub... Tech Exports Hit KRW 184 Trillion This YearĀ Ā ģ•„ģ‹œģ•„ź²½ģ œ

Google News

Oct 24, 2026, 10:00 PM

Yakima Chamber of Commerce hosts a drug take back with a drive-through Shreds and Meds event - Nonstop Local News

Yakima Chamber of Commerce hosts a drug take back with a drive-through Shreds and Meds eventĀ Ā Nonstop Local News

Google News

Oct 24, 2026, 9:20 PM

Panama positions itself as Latin American trade gateway for Tamil Nadu’s maritime and pharma industries - ET Government

Panama positions itself as Latin American trade gateway for Tamil Nadu’s maritime and pharma industriesĀ Ā ET Government

Google News

Oct 24, 2026, 8:41 PM

Teva Pharmaceutical Industries (TEVA) Stock Forecasts - Yahoo Finance

Teva Pharmaceutical Industries (TEVA) Stock ForecastsĀ Ā Yahoo Finance

Google News

Oct 24, 2026, 5:48 PM

China’s volume-based drug procurement linked to modest rise in R&D intensity - Bioengineer.org

China’s volume-based drug procurement linked to modest rise in R&D intensityĀ Ā Bioengineer.org

Google News

Oct 24, 2026, 4:08 PM

Treasury's COINS Rules Leave China Biotech Licensing Open — but the Joint-Venture Clause Could Close the Door - BigGo Finance

Treasury's COINS Rules Leave China Biotech Licensing Open — but the Joint-Venture Clause Could Close the DoorĀ Ā BigGo Finance

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer